Save on Molnupiravir with Coupons, Discounts & Savings Programs

Molnupiravir is available as a 200 mg oral capsule.

Molnupiravir is an antiviral and is used to treat mild-to-moderate COVID-19 in adults who are at high risk for severe illness and aren’t able to receive other FDA-authorized treatments.

Molnupiravir is a nucleoside analog that treats COVID-19 by targeting the virus. It works by disrupting the process that the virus uses to make copies of itself. This means the virus won’t be able to make any more copies of itself to further spread infection.

The typical dose is 800 mg (taken as four 200 mg capsules) by mouth every 12 hours for 5 days.

Molnupiravir is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you.

Common side effects of Molnupiravir:

• Diarrhea

Serious side effects are rare with Molnupiravir. Contact your healthcare provider immediately if you experience any of the following.

• Serious allergic reaction: feeling faint, dizziness, trouble breathing, swelling in the face, swollen tongue, difficulty swallowing, itchy skin, rash, hives, nausea, vomiting

There are no major drug interactions listed for Molnupiravir. However, always let your physician and pharmacist know about any other medications or supplements (including prescribed and over-the-counter medications, vitamins, and dietary or herbal supplements) that you are currently taking.

Various FDA-approved generic manufacturers

Based on animal data, Molnupiravir may cause fetal harm when administered to pregnant individuals. It should only be used during pregnancy if the benefit to you is worth the possible risk to your baby. There is a pregnancy registry that monitors pregnancy outcomes in individuals exposed to Molnupiravir during pregnancy. Encourage participation and advise patients about how they may enroll in the pregnancy registry at Covid PR registry  or 1-800-616-3791.

• Lagevrio